Genome sequencing and clinical diagnosis in 186 pediatric and adult patients with genetic skeletal disorders
Variant / mechanism
Pathogenic variants identified by short-read genome sequencing, with dominant (69%), recessive (24%) or X-linked (7%) inheritance
Summary
A cohort of 186 patients (182 unrelated families) with clinical and radiographic features of a genetic skeletal disorder was investigated by short-read genome sequencing between 2015 and 2022, with clinical and radiographic data reviewed according to the 2023 International Nosology. A molecular diagnosis was established in 134 of 182 families (73.6%): 125 at initial analysis (68.7%) and 9 after reanalysis or family-based investigations (4.9%). Autosomal dominant disorders accounted for 69% of diagnoses, autosomal recessive for 24% and X-linked for 7%. Variants of uncertain significance in phenotype-consistent genes were found in nine families, including biallelic variants in genes associated with dominant disease (COL10A1, UFSP2), and a likely non-genetic cause was identified in five families.
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
A yield close to three quarters confirms the effectiveness of genome sequencing in genetic skeletal disorders, provided it is backed by expert radiological review. The gain from reanalysis (4.9%) is modest but real. Biallelic variants in classically dominant genes (COL10A1, UFSP2) remain variants of uncertain significance at this stage and should not be read as diagnoses.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime